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The prevalence of asthma, measured either as the frequency of hospital admissions or number of deaths attributed to asthma, has increased over
the last 15 to 20 years. Rapid increases in disease prevalence are more likely to be attributable to environmental than genetic factors. Inferring from
past associations between air pollution and asthma, it is feasible that changes in the ambient environment could contribute to this increase in mor-
bidity and mortality. Scientific evaluation of the links between air pollution and the exacerbation of asthma is incomplete, however. Currently, criteria
pollutants [SOX, NOW, 03, CO, Pb, particulate matter (PM10)] and other risk factors (exposure to environmental tobacco smoke, volatile organic com-
pounds, etc.) are constantly being evaluated as to their possible contributions to this situation. Data from these studies suggestthat increases in res-
piratory disease are associated with exposures to ambient concentrations of particulate and gaseous pollutants. Similarly, exposure to
environmental tobacco smoke, also a mixture of particulate and gaseous air toxics, has been associated with an increase in asthma among children.
In addition, current associations of adverse health effects with existing pollution measurements are often noted at concentrations below those that
produce effects in controlled animal and human exposures to each pollutant alone. These findings imply that adverse responses are augmented
when persons are exposed to irritant mixtures of particles and gases and that current measurements of air pollution are, in part, indirect in that the
concentrations of criteria pollutants are acting as surrogates of our exposure to a complex mixture. Other irritant air pollutants, including certain
urban air toxics, are associated with asthma in occupational settings and may interact with criteria pollutants in ambient air to exacerbate asthma. An
evaluation of dose-response information for urban air toxics and biological feasibility as possible contributors to asthma is therefore needed.
However, this evaluation is compounded by a lack of information on the concentrations of these compounds in the ambient air and their effects on
asthma morbidity and mortality. Through an initial review of the current toxicological literature, we propose a tentative list of 30 compounds that
could have the highest impact on asthma and respiratory health. These compounds were selected based on their ability to induce or exacerbate
asthma in occupational and nonoccupational settings, their allergic potential and ability to react with biological macromolecules, and lastly, their abil-
ity to irritate the respiratory passages. We recommend better documentation of exposure to these compounds through routine air sampling and
evaluation of total exposure and further evaluation of biological mechanisms through laboratory and epidemiological studies directed specifically at
the role these substances play in the induction and exacerbation of asthma. - Environ Health Perspect 103(Suppl 6):253-271 (1995)
Key words: asthma, hazardous air pollutants, volatile organic compounds, aldehydes, environmental, tobacco smoke, ambient aerosols,
chronic obstructive pulmonary disease.
Introduction
UrbanAirToxics
The Title III-Hazardous Air Pollutants
portion of the 1990 Clean Air Act
Amendment mandates the preparation of
exposure standards for an initial list of 189
compounds within 6 years and a compre-
hensive strategy to control emissions from
sources in urban areas within 5 years. The
latter requires an identification of not less
than 30 hazardous air pollutants that pre-
sent the greatest threat to public health in
the largest number of urban areas. Several
health concerns are to be considered, with
emphasis on carcinogenicity, mutagenicity,
and teratogenicity. In the review that fol-
lows, we consider the possible relationship
between these compounds and an addi-
tional disease, asthma. Asthma morbidity
(emergency room visits, etc.) and mortality
have steadily increased since the mid-I970s,
a situation that will require a better under-
standing ofenvironmental risk factors.
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Clean air is essential for life. Human
commerce and recreation have led to the
purification, development, and macroscale
use ofover 50,000 chemicals. Each can be
considered toxic depending on the magni-
tude ofexposure, the dose to target organ,
and the biological response. Systematic
evaluation and reevaluation ofthe toxicology
of these chemicals is ongoing and may
require many decades ofeffort to under-
stand the relationships between environ-
mental exposure and potential to cause or
exacerbate human diseases. Faced with the
immediate need to protect human health
by providing recommendations for over
180 compounds (Table 1), referred to here
as urban air toxics (UATs), we attempt to
rank this substantial list of compounds
(and groups ofcompounds). Any prioriti-
zation should be based on the likelihood
and extent of human exposure and the
severity of the response. Unfortunately,
adequate scientific details are lacking for
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Table 1. Urban airtoxics, the 189 substances listed in the 1990 Amendment to the Clean AirAct as hazardous air pollutants.
ACETALDEHYDE
ACETAMIDE
ACETONITRILE
ACETOPHENONE
2-ACETYLAMINOFLUORENE
ACROLEIN
ACRYLAMIDE
ACRYLIC ACID
ACRYLONITRILE
ALLYL CHLORIDE
4-AMINOBIPHENYL
ANILINE
o-ANISIDINE
ASBESTOS
BENZENE
BENZIDINE
BENZOTRICHLORIDE
BENZYL CHLORIDE
BIPHENYL
biW2-ETHYLHEXYL) PHTHALATE
bWCHLOROMETHYL) ETHER
BROMOFORM
1,3-BUTADIENE
CALCIUM CYANAMIDE
CAPROLACTAM
CAPTAN
CARBARYL
CARBON DISULFIDE
CARBON TETRACHLORIDE
CARBONYL SULFIDE
CATECHOL
CHLORAMBEN
CHLORDANE
CHLORINE
CHLOROACETIC ACID
2-CHLOROACETOPHENONE
CHLOROBENZENE
CHLOROBENZILATE
CHLOROFORM
CHLOROMETHYL METHYL
ETHER
CHLOROPRENE
CRESOLS/CRESYLIC ACID
o-, m-, p-CRESOL
CUMENE
2,4-D, SALTS AND ESTERS
DICHLORODIPHENYLDICHLOROETHYLENE
DIAZOMETHANE
DIBENZOFURANS
1,2-DIBROMO-3-CHLOROPROPANE
DIBUTYLPHTHALATE
1,4-DICHLOROBENZENE (p)
3,3-DICHLOROBENZIDENE
DICHLOROETHYL ETHER
(or) bis2-CHLOROETHYL) ETHER
1,3-DICHLOROPROPENE
DICHLOROVOS
DIETHANOLAMINE
N,N-DIETHYL ANILINE
(or) N,N-DIMETHYLANILINE
DIETHYL SULFATE
3,3-DIMETHOXYBENZIDINE
DIMETHYL AMINOAZO-BENZENE
3,3'-DIMETHYL BENZIDINE
DIMETHYL CARBAMOYL CHLORIDE
DIMETHYL FORMAMIDE
1,1-DIMETHYL HYDRAZINE
DIMETHYL PHTHALATE
DIMETHYL SULFATE
4,6-DINITRO-o-CRESOL AND SALTS
2,4-DINITROPHENOL
2,4-DINITROTOLUENE
1,4-DIOXANE
(or) 1,4-DIETHYLENEOXIDE
1,2-DIPHENYLHYDRAZINE
EPICHLOROHYDRIN
(or) 1-CHLORO-2,3-EPOXYPROPANE
1,2-EPOXYBUTANE
ETHYL ACRYLATE
ETHYL BENZENE
ETHYLCARBAMATE (URETHANE)
ETHYLCHLORIDE (CHLOROETHANE)
ETHYLENE DIBROMIDE
ETHYLENE DICHLORIDE
ETHYLENE GLYCOL
ETHYLENE IMINE(AZIRIDINE)
ETHYLENE OXIDE
ETHYLENETHIOUREA
ETHYLIDENE DICHLORIDE
(or) 1,1-DICHLOROETHANE
FORMALDEHYDE
HEPTACHLOR
HEXACHLOROBENZENE
HEXACHLOROBUTADIENE
HEXACHLOROCYCLOPENTADIENE
HEXACHLOROETHANE
HEXAMETHYLENE-1,6-DIISOCYANATE
HEXAMETHYLPHOSPHORAMIDE
HEXANE
HYDRAZINE
HYDROCHLORIC ACID
HYDROGEN FLUORIDE
HYDROGEN SULFIDE
HYDROQUINONE
ISOPHORONE
LINDANE
MALEIC ANHYDRIDE
METHANOL
METHOXYCHLOR
METHYL BROMIDE (BROMOMETHANE)
METHYL CHLORIDE (CHLOROMETHANE)
METHYL CHLOROFORM
(or) 1,1,1-TRICHLOROETHANE
METHYL ETHYL KETONE (2-BUTANONE)
METHYL HYDRAZINE
METHYL IODIDE(IODOMETHANE)
METHYL ISOBUTYL KETONE (HEXONE)
METHYL ISOCYANATE
METHYL METHACRYLATE
METHYLENE-tert-BUTYL ETHER
4,4-METHYLENE BIS(2-CHLOROANILINE)
METHYLENE CHLORIDE
METHYLENE DIPHENYL DIISOCYANATE
4,4'-METHYLENEDIANILINE
NAPHTHALENE
NITROBENZENE
4-NITROBIPHENYL
4-NITROPHENOL
2-NITROPROPANE
N-NITROSO-N-METHYLUREA
N-NITROSODIMETHYLAMINE
N-NITROSOMORPHOLINE
PARATHION
PENTACHLORONITROBENZENE
(or) QUINTOBENZENE
PENTACHLOROPHENOL
PHENOL
p-PHENYLENEDIAMINE
PHOSGENE
PHOSPHINE
PHOSPHORUS
PTHALIC ANHYDRIDE
POLYCHLORINATED BIPHENYLS (PCB)
1,3-PROPANE SULTONE
P-PROPIONALDEHYDE
PROPIONALDEHYDE
PROPOXUR (BAYGON)
PROPYLENE DICHLORIDE
PROPYLENE OXIDE
1,2-PROPYLENIMINE
(or) 2-METHYL AZIRIDINE
QUINOLINE
QUINONE
STYRENE
STYRENE OXIDE
2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN
(TCDD)
1,1,2,2-TETRACHLOROETHANE
TETRACHLOROETHYLENE
TITANIUM TETRACHLORIDE
TOLUENE
2,4-TOLUENE DIAMINE
2,4-TOLUENE DIISOCYANATE
o-TOLUIDINE
TOXAPHENE
1,2,4-TRICHLOROBENZENE
1,1,2-TRICHLOROETHANE
TRICHLOROETHYLENE
2,4,5-TRICHLOROPHENOL
2,4,6-TRICHLOROPHENOL
TRIETHYLAMINE
TRIFLURALIN
2,2,4-TRIMETHYLPENTANE
VINYL ACETATE
VINYL BROMIDE
VINYL CHLORIDE
VINYLIDENE CHLORIDE
(or) 1,1-DICHLOROETHYLENE
XYLENES (ISOMERS AND MIXTURES)
o-, m-, p-XYLENES
ANTIMONY COMPOUNDS
ARSENIC COMPOUNDS (INORGANIC
INCLUDING ARSINE)
BERYLLIUM COMPOUNDS
CADMIUM COMPOUNDS
CHROMIUM COMPOUNDS
COBALT COMPOUNDS
COKE OVEN EMISSIONS
CYANIDE COMPOUNDS
GLYCOL ETHERS
LEAD COMPOUNDS
MANGANESE COMPOUNDS
MERCURY COMPOUNDS
FINE MINERAL FIBERS
NICKEL COMPOUNDS
POLYCYCLIC ORGANIC MATTER
RADIONUCLIDES (INCLUDING RADON)
SELENIUM COMPOUNDS
many ofthese compounds; therefore, we
also present information on the current gaps
in the toxicology literature and recommend
research needs that may be useful in reduc-
ing the uncertainty offuture evaluations of
the health effects ofthese compounds.
PersonswithAsmaandIncreased
Susceptibility toAirPolution
Air quality standards are designed to pro-
tect susceptible populations, and persons
with asthma are clearly at increased risk
from the adverse health effects ofair pollu-
tion. Because asthma is a complex respira-
tory condition with varied definitions
(1-3), it is helpful to develop an opera-
tional definition ofthis disease. Asthma is
defined here as a respiratory disease with
three primary features. The first is airway
inflammation (associated with eosinophilic
infiltration and altered T-cell lymphocytic
function). A second feature is altered
epithelial function (associated with thick-
ening ofthe basement membrane, mucin
hypersecretion, loss or altered ciliary struc-
ture, and altered cytokine and other
inflammatory mediator production). The
third and most predominate feature is
recurrent airflow obstruction (presented in
dual phases as decreased forced expiratory
volume, bronchospasm, or airway hyperre-
activity). Although the frequency of
asthma is greater among atopic individuals
(4), not all persons with asthma (e.g.,
more than half the adults with occupa-
tional asthma) (5) exhibit specific anti-
gen-antibody responses. Instead, these
individuals respond to many agents
including dry air, hypo/hypertonic
aerosols, acidic aerosols, and sulfur diox-
ide. Consequently, this condition is called
nonspecific airway hyperreactivity, which
many clinical investigators consider the
hallmark ofasthma (2,6).
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Although asthma may persist for many
years, the signs and symptoms are markedly
erratic both in frequency and severity. In
some ways, this intrinsic, sporadic nature
contributes to the licentiousness of this
disease. Severe, life-threatening asthmatic
attacks can arise rapidly even after presen-
tation ofmild symptoms to which the vic-
tim is accustomed. Thus, patients and
physicians may depend solely on self-
administered bronchodilators for therapy
assuming relief is shortly in hand, only to
be faced with a rapidly mounting array of
irreversible changes (e.g. airway obstruc-
tion by mucus inspissation). Indeed, this
lack ofappreciation for this condition by
patients and general practitioners has been
cited as contributing to the recent increases
in asthma mortality (7,8).
One factor that has been considered as
having a possible role in the recent
increases in asthma mortality is the use of
bronchodilator therapy (9-11). Without
recognition of the inflammatory and
epithelial components of this disease,
therapies directed solely at preventions of
bronchospasm can leave a persistent
inflammatory condition unchecked. In
addition, patients relieved of symptoms
may be more likely to put themselves in
harm's way by not avoiding environmental
exposures that increase epithelial injury
and may hasten acute attacks. In addition,
bronchodilation will alter the deposition
pattern ofsubsequently inhaled irritant
particles increasing their penetration to dis-
tal, small diameter airways and lengthening
clearance times.
In the past, controlled human expo-
sures ofpersons with asthma indicate that
these patients respond to bronchoconstric-
tive substances at lower concentrations
than do healthy control subjects (12). Of
the current criteria pollutants, SO2
(13,14), NO2 (15-18), and acidic sulfates
(19-23) can produce bronchoconstriction
(or increase bronchial reactivity) at lower
concentrations among asthmatic subjects.
Clinical studies with ozone are more con-
troversial (24-26), although a recent
study by Molfino (27) suggests that 03
exposures can increase bronchial reactivity
to subsequent antigen challenges in per-
sons with airway hypersensitivity. Results
from these studies qualitatively indicate
that specific pollutants affect persons with
asthma to a greater extent than healthy
subjects. However, clinical findings are
quantitatively disparate from epidemio-
logical findings in that in clinical studies,
the lowest effective concentration that
produces bronchoconstriction is often
higher than that noted to produce adverse
pulmonary effects when subjects are
exposed in free-roving environments.
Because asthma varies in its severity, a
selection bias of subjects with milder
forms of the disease could be responsible
for the difference noted between clinical
and epidemiological studies.
In several recent epidemiological stud-
ies, associations between air pollution and
the prevalence of respiratory symptoms
characteristic of asthma have been noted
throughout the world (Table 2). When
atopic and nonatopic patients were han-
dled separately, the association with air
pollution was unaffected (31,33,34). This
suggests that both asthma subpopulations
are affected equally by air pollution.
Besides increases in symptoms, air pollu-
tion has been associated with decreases in
pulmonary function, e.g., depressed forced
expiratory volume-1 second (FEVy) or
peak expiratory flowrate (PEF) (35,36).
Emergency department visits and hos-
pital admissions for asthma have also been
consistently associated with the amount of
exposure to air pollution (Table 3). The
implicated air pollution variable differs
among studies, with the most frequent
being particulate, sulfate, and sulfur diox-
ide. In contrast, earlier studies failed to
find similar associations with SO2 and
hospital admissions for asthma (47).
Several additional observations have
been noted by the investigators of these
studies. Although weather, pollen, and
environmental tobacco smoke are impor-
tant risk factors in asthma, each has been
found to act independently ofair pollution
and thus do not explain the association
between air pollution and asthma
(32,41,44,48-50). Local stationary sources
are often associated with effects
(31,38,45,51-57). This observation, along
with the observation that a variety ofpollu-
tants are associated with the same responses
(Tables 2,3), suggests that the specific
compounds measured may serve as indica-
tors of a wider array of air pollutants
(including UATs). By focusing on selected
epidemiological studies that have been con-
ducted in the last 5 years, emphasis is
placed on the current effects ofair pollu-
tion. All the reported associations have
been noted during a period when criteria
pollutants are either decreasing or main-
taining levels noted in previous years
(50,58). Last, because some recent studies
are cross-sectional over short periods, it is
unlikely that any recent changes in diagnos-
tic criteria for asthma could explain these
associations (59-62). Together these stud-
ies indicate that air pollution is a complex
mixture that can produce effects at current
levels ofexposure that are important to the
etiology ofasthma.
Table 2. Recent epidemiologic studies associating air pollution with increased prevalence of respiratory symp-
toms (wheezing, chesttightness, cough) in persons with asthma.
Studypopulation
Children
Children and adults
Adults
Children
Children and adults
Children
Implicated pollutants)
PM10
Particulate, NOX, 03
Particulate, H+
SO2
Particulate
Particulate, SO2
Location
Utah Valley, Utah
Helsinki, Finland
Denver, Colorado
New So. Wales, Australia
Pite3, Sweden
Rome, Italy
Investigator
Pope (28)
Ponk3 (29)
Ostro (30)
Henry (31)
Forsberg (32)
Corbo (33)
"Particulate <10 pm.
Table 3. Recent epidemiologic studies associating air pollution with increases in hospital admissions or emer-
gency room visits forasthma.
Study population Implicated pollutants) Location Investigator
Children and adults SO4, SO2, 03 Ontario, Canada Bates (37)
Children 03 Six U.S. cities Dockery (38)
Children SO2 Oporto, Portugal Queir6s (39)
Children SO2 Hong Kong Tseng (40)
Adults SO4, SO2 Vancouver, Canada Bates (41)
Children PM10a Utah Valley, Utah Pope (28)
Children and adults 03 Northern NewJersey Cody(42)
Children Particulate Melbourne, Australia Rennick (43)
Severe adults Particulate, NO2, SO2, H2S Oulu, Finland Rossi (44)
Children and adults PM 0a Seattle, Washington Schwartz (45)
Children and adults 03 Central NewJersey Weisel (46)
'Particulate <10 pm.
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Exposure Assessment
EntryandFate in theEnvironment
Exposure is a primary issue regarding the
culpability ofUATs in the exacerbation of
asthma. This is an extremely complex issue
for this group ofcompounds. Ideally, exist-
ing air sampling networks could quantify
hourly, daily, or yearly the ambient con-
centrations of all these 189 compounds.
Evaluation of a massive data collection
effort and its effectiveness in
control-design strategies is well beyond the
limited scale of this review. Nonetheless,
appreciation for the magnitude of this
problem and a preliminary understanding
of exposure assessment is necessary to
begin to evaluate whether such a future
undertaking would have merit.
UATs can enter the environment by a
complex array ofpathways. Vaporization of
gases is the primary route of entry and is
often a consequence of fugitive emissions
from stationary sources. This process
depends on the intrinsic physical/chemical
properties of each compound including
vapor pressure and solubilities in various
media (i.e., water, organic solvents, etc.) as
well as certain attributes of the manufac-
turing and generating procedures (e.g., the
temperature of the effluent). Highly
volatile substances can more readily escape
into the ambient air and thus have added
concern. Emission inventories for UATs
indicate that release into the air is the prin-
cipal route through which these materials
enter the environment (Figure 1).
In addition to direct entry from sta-
tionary sources by volatilization, specific
compounds can enter the urban air by
40
30 -
CD
m 20- *a
cL CL
10
0
Air Under Off- Land Public Surface
ground site sewage water
Figure 1. Distribution of toxic chemicals into the envi-
ronment by route of release ortransfer estimated from
release inventories in 1989. Data from U.S. EPA(63).
mechanical dispersion or condensation,
processes that dominate the formation of
the urban aerosol. Urban aerosols have
been chemically characterized to a limited
extent in the past (64-71). However, the
past and current criteria pollutants, total
suspended particulate (TSP), and particulate
material < 10 pm (PMlo) overlap with
specific UATs because particles in this size
range and smaller are derived from anthro-
pogenic sources, whereas larger particles
(>10 pm) arise from natural sources (e.g.,
sea salt, soil, etc.). More details ofthe impli-
cation ofthe ambient levels ofparticulate
matterto asthma arepresented below.
A third source of atmospheric pollu-
tants arises from secondary reactions in the
atmosphere. Many reactive hydrocarbons
(often with very short half-lives) can be
formed and can accumulate in the atmos-
phere (72-76). This is particularly impor-
tant for urban photo-oxidant plumes most
often associated with ozone formation.
Because ozone formation is dependent
upon reactive hydrocarbon species (e.g.,
aldehydes), the continuous measurement
ofozone concentrations could be useful in
estimating the ambient concentrations of
these compounds. Once inhaled, ozone is
likely to react with unsaturated fatty acid
in the airway lining fluid or the cell mem-
brane to form aldehydes, hydroxyhydro-
peroxides, and hydrogen peroxide (77,78).
These intermediates have recently been
shown to activate mediator release from
human airway epithelial cells in culture,
thereby linking the biochemical outcomes
of ozone with these compounds (79).
Reductions in the emissions of ozone pre-
cursors (hydrocarbons and nitrogen oxides)
are likely to limit indirectly the entry of
certain UAT compounds into the atmos-
phere in the future. Urban activities of
automobile transit, power generation,
manufacturing, solvent use, wood burning,
and even barbecuing have impact on the
formation and release ofthese compounds.
Besides direct entry into the air and sec-
ondaryformation, other chemicals can gain
significant entry into the atmosphere
through intermediate transport. In this
case, chemicals that partition into water,
soil, sediment, or biota can enter the
atmosphere through evaporation from
water or soil. For example, organic com-
pounds with low or moderate solubility in
water will partition to the air-liquid inter-
face following an initial dispersion as an
emulsion in a factory effluent stream.
Thus, continuous and sole discharge into
water can unexpectedly generate significant
atmospheric concentrations. For example,
recent fugacity models, e.g., Level III mod-
els by Mackay (80), predict that as much
as 5% of naphthalene (a water-insoluble
chemical with moderate volatility) will be
distributed into the air when 100% is dis-
charged into water. Although such a per-
centage seems low, the impact can be
considerable. For example, dispersion of
naphthalene solely into water at an emission
rate of 1000 kg/hr (distributed throughout
100,000 km2 or about the area of Ohio)
can yield atmospheric concentrations of50
3 ng/m . This is approximately one quarter
ofthe value achieved by 100% emission of
the same amount directly into the air (210
ng/m3) when fugacity into other media is
considered. This is somewhat remarkable
and may partially explain why concentra-
tion estimates produced by airshed models
that depend heavilyon air emission invento-
ries underpredict measurements made in the
ambient air downwind from a point source
(MAMarty, personal communication).
The movement of toxics from the air
into other media and back again suggests
an equilibrium can be achieved or pre-
dicted. However, uniform dispersion is
unlikely in any compartment in real world
situations. Furthermore, such models have
uncertainty in estimating degradation rates
in each compartment.
Degradation in the air itself can be
appreciable and can even be sufficient to
limit exposure. Naphthalene, the chemical
used in the example above, is rapidly pho-
tolyzed. Based on the quantum yield for
sunlight photolysis at latitude 400N at
midday in the summer, the half-life of
naphthalene can vary markedly from 71 to
550 days (81). In addition, photooxidation
through reactions with hydroxyl radicals
(often produced in urban plumes) can dra-
matically reduce the half-life ofnaphtha-
lene to between 3 and 30 hr. Such variance
in the environmental degradation rates can
widely influence air concentrations.
This latter situation presents another
dilemma facing attempts to assess human
exposure to UATs. Exposure to many of
these compounds is likely to be dominated
by proximity to point sources that produce
intermittent, high concentrations as well as
regional meterology, atmospheric disper-
sion, transport, and removal. Source-
receptor analysis is therefore important.
This attribute places significance on the
identification ofsensitive receptors in the
population downwind from a point source.
Because persons with asthma constitute
approximately 3.8 to 8.7% ofthe residents
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of urban areas (82,83), this group repre-
sents an important target population and
should be considered as such in evaluation
ofpossible risks associated with exposure
that could enter the neighborhoods of
emission sources.
ExposureAssessment,Threshold
Concentrations, andtheInduction
ofAsthma
We have learned a great deal about the
induction of chemically induced asthma
from occupational experience. In this set-
ting, exposure can still be difficult to quan-
tify, but causal association can more readily
be demonstrated. For example, polyiso-
cyanate-induced asthma has clearly been
ascribed to exposure in the workplace.
Historically, approximately 5 to 10% ofall
workers exposed to toluene diisocyanate,
other polyisocyanates, and their monomeric
precursors develop occupational asthma
(5). Although host determinants (genetic
factors) can modulate asthma, exposure to
specific, identifiable agents is clearly associ-
ated with the development ofasthma. This
condition typically develops after several
years ofoccupational exposure, indicative
of a latency period when exposures are
occurring while subjects are asymptomatic.
Several ofthese compounds are included in
the UAT list, and this selection of com-
pounds ofconcern in the ambient environ-
ment draws from the experience in the
occupational environment.
Current control strategies are designed
to reduce occupational exposure concentra-
tions below threshold limit values (TLVs).
Exposures at these levels should ideally
result in few or no adverse health effects.
This approach from the occupational expe-
rience impinges directly on the method of
application ofrisk assessment for noncancer
health effects. However, although expo-
sures have qualitatively been associated
with occupational asthma, quantification
ofhuman exposure to a specific compound
has been limited. Mathematical models of
the relationship between dose (the concen-
tration and duration of exposure) and
occupational asthma have yet to be firmly
established. Nonetheless, current occupa-
tional standards assume that a threshold
dose can be established at which no addi-
tional cases of asthma will develop.
However, this assumption may be flawed.
For example, initiation of occupational
asthma has been noted among workers
wearing respiratory protective equipment
andwhen exposures met current TLVs (5).
Induction of airway hyperre
animals provides some insigh
issue of threshold dose. For ex
recently examined the induction
reactivity in guinea pigs ex
formaldehyde and acrolein (84
studies, the dose ofacetylcholine
to double pulmonary resistanc
was measured after 2- and 8-hr
Figure 2 shows that exposures e:
8 hr produced an effect greater
predicted by the common est
dose. After 8 hr of exposure tc
formaldehyde, the percentage
ED200 equaled 67 ±4%. This is
to the maximal effect produced
exposure to either .30 ppm fori
or > 1.0 ppm acrolein. Thus the
dose-response relationship for
induced hyperreactivity after 1
exposure did not follow a simp
tration x time relationship
CD
CD
cJ
i n 0
a,
OC
co
C.)
.C,
E
x 60-
40-
20-
HCHO
0.1 1 10
log[aldehyde], pprn
Figure 2. Dose-response effects
(CH2=CH-CHO) or formaldehyde (HCHI
hyperreactivity in guinea pig. (A) Two-hc
to acrolein or formaldehyde produce
decrease in the effective dose of intravi
choline necessary to double specific puli
tance (ED200) at concentrations of >0.9
respectively. (B) When exposures were E
hr, a dose of 1.0 ppm formaldehyde produ
equivalent to that following 30 ppm x 2 1
means ± SE of groups of five to seven
Data from Swiechichowski (84).
activity in equivalent response occurred after 1.1 ppm
t into the x 8 hr = 8.8 ppm x hr that is nearly 7
ample, we times less than what would be predicted by
1 ofhyper- 31 ppm x 2 hours = 62 ppm x hr). These
posed to findings suggest that low-level exposure of
). In these prolonged duration may be ofgreater con-
e necessary sequence than would be predicted by acute
e (ED200) exposure. This would explain why some
exposures. clinical studies with exposures of short
extended to duration (<4 hr) do not uncover effects at
than that levels that are associated with pulmonary
timates of effects in epidemiological studies.
) 1.1 ppm Induction of irritant-induced asthma
change in without a latency period has also been
equivalent reported extensively in the medical literature
by 2 hr of and has been termed reactive airways dys-
maldehyde function syndrome (RADS) (85). The
estimated pathogenesis ofthis syndrome is speculative
aldehyde- because reports are retrospective in nature.
prolonged Typically, patients without pre-existing res-
ile concen- piratory complaints develop airway hyperre-
(i.e., an activity shortly after an accidental exposure
or an exposure in an area with no or poor
ventilation. Following this single exposure,
2-hrexposure hyperreactivity and abnormal bronchial
epithelial biopsies persist for ayear or longer
(up to 12 years). Causative agents have var-
ied greatly, but all are respiratory irritants
HO and include chlorine (86-88), toluene diiso-
cyanate (89-91), hydrazine (85), sulfur
dioxide (92,93), acetic acid (94), and
ammonia (95,96). This condition differs
from typical occupational asthma because it
lacks a preceding latent period and can be
-,-,-,-,-,, initiated by a single exposure. Persons with
100 this syndrome often experience subsequent
responses to a wide range ofagents (non-
8-hrexposure specific airway hyperreactivity) and workers
report that symptoms are equivalent either
at home or at work (97-100). Because ofa
lack ofexposure measurements during the
initiating events, is it difficult to establish a
threshold for this type ofresponse; nonethe-
less, it is assumed that very high exposure
levels are responsible for these cases.
ExposureAssessmentand
theExacerbationofAsthma
100 In addition to scientific uncertainties associ-
ated with the establishment of threshold
of acrolein doses for chemicals that induce asthma, the
I) on airway levels ofoccupational exposure necessary to
)ur exposures cause the persistence ofsensitization or to
d a maximal elicit responses upon reexposure have yet to
enous acetyl- be established. Often the exposure concen-
maonda3y ppsm- tration necessary to produce a multi-phasic
extended to 8 response of diminished lung function in
iced an effect persons already sensitive to a compound can
hr. Values are be exquisitely low, well below the concen-
guinea pigs. tration that will cause bronchoconstriction
in nonsensitized persons exposed in clinical
Volume 103, Supplement 6, September 1995 257LEIKAUFETAL.
experiments. However, epidemiological
data of dose- response relationships in
occupational settings are lacking and lim-
ited to anecdotal case histories. For exam-
ple, one worker sensitive to ampicillin
reportedly developed asthmatic bron-
chospasm the night after (delayed allergic
response) a visit to the town where the fac-
tory that produces ampicillin is located. In
another case, a toluene diisocyanate-sensi-
tive patient was so reactive that he
responded when walking in the neighbor-
hood of a factory (101). Another
cololphony (rosin)-sensitive worker became
reactant to pine trees and even unheated
colophony or turpentine (102). In addi-
tion, broncoprovocation tests have been
positive in previously sensitized workers
after exposure at concentrations as low as
the current limit ofchemical detection, i.e.,
7 pg/mi3 toluene diisocyanate (103,104).
These histories indicate that once initiation
ofhypersensitivity has occurred, elicitation
of response can be evoked upon minimal
reexposure at extremely low concentrations.
Thus, for these individuals any environ-
mental exposure should be considered haz-
ardous, and any attempt to set threshold
doses for this susceptible population (that
could provide a margin ofsafety) must be
regarded as extremely tenuous.
ExposureAssessmentfiomProbability-
BasedSampling Procedures
Because exposure assessment for UATs is
currently incomplete, several strategies
must be developed to reduce uncertainty.
One approach is to use probability-based
survey sampling procedures that combine
questionnaires with multimedia and multi-
pathway monitoring to estimate total per-
sonal exposure. A recent example is a study
by Whitmore et al. (105) in which non-
occupational exposure to 32 pesticides was
assessed (Table 4). Air monitoring was per-
formed outside and inside each home, and
drinking water, food, and dermal routes of
exposure were analyzed. Ten ofthese pesti-
cides are on the UAT listing, and other
studies have found associations between
the use ofpesticides and asthma (106).
Inhalation exposure exceeded dietary expo-
sure for four ofthese substances (chlordane,
dichlorovos, heptachlor, and propoxur)
with the concentrations being approxi-
mately 7 to 20 times greater indoors than
outdoors. Dietary exposures were greater
for five other UAT/pesticides (captan, car-
baryl, DDT and related compounds, hexa-
chlorobenzene, and methoxychlor), and
Table 4. Weighted estimates of average dailyairconcentrations and cancer risk assessment for eight urban air
toxics forJacksonville, Florida, and Springfield/Chicopee, Massachusetts.a
Average daily
concentration, Excess lifetime Referencedose,
Airtoxic ng/m3 b cancer riskx 10-6C ng/kg-dayd Hazard indexe
Jacksonville
Chlordane 197.0 70.0 0.06 1.0
Heptachlor 115.0 200.0 0.5 0.07
Dichlorvos 62.0 - 0.8 0.02
Propoxur 185.0 0.4 4.0 0.01
ytBHC 11.0 - 0.3 0.01
DDE, etc. 0.6 0.06 0.5 0.0003
Carbaryl 7.5 - 100.0 2xl05
Methoxychlor 0.3 - 50.0 2x104
Springfield/Chicopee
Chlordane 198.0 70.0 0.06 1.0
Heptachlor 27.0 - 0.5 0.02
Dichlorvos 3.3 - 0.8 0.001
Propoxur 15.0 0.03 4.0 0.001
y-BHC 1.9 - 0.3 0.002
DDE, etc. 3.8 0.4 0.5 0.0005
Carbaryl 0.1 - 100.0 3x107
Methoxychlor 7.0 - 50.0 <5x10 5
'Adapted from Whitmore (105). bAverage daily concentration measured using personal air exposures. OCancer risk
. 1E-06 is generally considered negligible by U.S. EPA. dSee Whitmore (105)for sources. 'A hazard index value of
. 1 is generally considered negligible bythe U.S. EPA.
the relative level ofexposure for one sub-
stance (y-BHC) was undeterminable.
Based on these estimates ofpersonal
exposure, risk assessments for air exposure
were presented assuming a constant expo-
sure over a 70-year lifetime and reference
doses from the Integrated Risk Information
System (IRIS) and other sources. The
inhalation risks were estimated to be negli-
gible (< Ix106) for all compounds except
chlordane (Table 4). However, these
authors noted that these estimates are
potentially high because ofthe discontinu-
ation ofuse ofthese compounds and vari-
able degradation in the environment. The
data were considered insufficient to sup-
port risk assessment for food, dermal con-
tact, or house dust exposure. Because
indoor exposure may be due to past use in
the home, it is also important to consider
the possible risk due solely to outside expo-
sure. For chlordane in Jacksonville,
Florida, the estimated outside air exposure
levels equaled about 22 ng/m3 (compared
to 197 ng/m3 indoors), or about 10% of
that used in the above risk assessment esti-
mate. Thus, because exposure to other
UATs also may be greater indoors than
outdoors, accurate exposure assessment
requires detailed analyses that involve total
exposure evaluations. In addition, the
above study is limited to only two loca-
tions, and these findings may not be readily
generalized to other regions and climates.
PossibleEposure Concentrations
ofUATsIndoors
Assessment ofpossible human exposure for
these compounds clearly requires considera-
tion ofexposure in the indoor environment.
Table 5. Estimates of indoor air concentrations and odorthresholdfor the 10 most reported volatile organic
compounds/air toxics.
Indoorairconcentrations,apg/mi3 Lowest odor
Airtoxic Minimum Maximum Mean threshold, bpg/M3
Formaldehyde 8.0 634 98.0 60
Toluene 9.0 2252 56.0 8030
Trichloroethane <1.0 880 19.0 2 x 106
Ethylbenzene 1.5 800 11.0 400
1,4-Dichlorobenzene <0.6 1006 9.7 9 x 104
Acetaldehyde 2.1 48 9.6 1980
Tetrachloroethylene 1.0 617 9.5 3 x 104
Trichloroethylene <1.0 >5 x 10 6.0 1 x 106
Benzene <1.0 6338 5.1 4600
Xylenes 1.2 2076 3.8 348
"Concentrations from Samfield (107). bOdorthresholds are lowestvalue reported.
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Table 6. Estimates of indoor air concentrationsa and odorthreshold for 13 frequently reported volatile organic
compounds/air toxics.
Indoor airconcentrationsa Jg/m3 Lowest odor
Airtoxic Minimum Maximum Mean threshold,bpg/M3
Methylene chloride ND 5000 342.0 5 x 106
Carbon tetrachloride 0.4 33 12.0 1 x 106
Naphthalene <1.0 676 11.0 -
n-Hexanes 2.0 590 9.3 -
Chloroform 0.07 210 5.8 3 x 106
2-Butanone <1.0 41 5.3 800
Pentachlorobenzene ND 39 3.1 -
Styrene <1.0 54 1.8 200
Chlorobenzene <0.4 27 <1.7 1060
Trichlorobenzene ND 33 <0.8 -
N-Nitrosodimethylamine ND 33 0.17 -
Quindone 0.0013 0.031 0.03 4x 104
Hexachlorobenzene ND 0.021 0.001 -
ND, not detected or below the lower detection limit. "Concentrations from Samfield (107). hOdor thresholds are
lowest value reported.
Recently, the U.S. EPA compiled a data-
base of concentrations ofvolatile organic
compounds (VOC) measured indoors
(107). Based on reports from 1979
through 1990, information on over 220
compounds ranging from 30 to 446
Daltons molecular weight was recorded.
Table 5 lists the 10 most frequently
reported compounds. Concentrations are
presented as the minimum and maximum
values to present a range (these values are
the lowest and highest value obtained from
all recorded values), mean values (esti-
mated as a mean of the mean values
reported), and lowest odor threshold. The
concentrations of 13 other UATs fre-
quently measured indoors are presented in
Table 6. The odor threshold for each com-
pound (except formaldehyde) is typically
orders ofmagnitude higher than measured
values, even when the lowest odor threshold
value is considered. This suggests that
human exposures can frequently occur
when the odor is imperceptible. Comple-
mentary to this observation is the likelihood
that olfactory detection indicates high
exposure. The odor threshold for many of
these compounds (Tables 5,6) is well above
its recent reference exposure guideline
(Tables 7,8). Because complaints of mal-
odorous emissions are common outdoors
near point sources, this comparison sug-
gests that local exposures can be significant.
An earlier total exposure assessment
methodology (TEAM) study had measured
many of the same compounds (108),
determining the concentrations of 20
VOCs in personal air, outdoor air, expired
breath, and drinking water. The median
concentrations in air and breath of 10 of
the more prevalent compounds are pre-
sented in Table 7. Each is included on the
list of urban air toxics (Table 1). Personal
concentrations often exceeded outdoor
concentrations by a factor of2 or greater in
New Jersey, and by a factor of 5 to 10 in
North Carolina and North Dakota. This
suggests that indoor VOC sources are
likely to be ofgreater significance than out-
door sources. In addition, the distributions
of the measurements were skewed, with
geometric standard deviations ranging
from 2.5 to 3.5, which means the range of
the concentrations usually exceeded a fac-
tor of 100 to 1000. Proximity to point
sources (defined as 1.5 km from asuspected
source) was stratified and had little influence
on air or breath measurements. In contrast,
personal activities including occupation,
smoking or livingwith a smoker (increasing
expired benzene, styrene, ethylbenzene and
other aromatic hydrocarbons), filling a gas
tank (doubling expired benzene), and visit-
ing a dry cleaner or wearing dry-cleaned
clothing (increasing expired trichloroethyl-
ene with a half-life of>20 hr) significantly
contributed to the levels ofcertain com-
pounds measured in expired breath.
In similar investigations of indoor air
quality, Molhave and associates (109-112)
measured the concentrations of several
VOCs in Denmark. Using these data, the
authors presented the concept of total
VOC exposure in which the concentration
ofa mixture of22 compounds is weighted
by their relative concentrations in the envi-
ronment. This group of compounds
excludes carcinogens and includes 10 sub-
stances most frequently present in the
atmosphere in new homes and 10 sub-
stances in greatest concentrations in non-
industrial buildings in which complaints
had been recorded about quality of the
indoor air (Table 8). Because ofthe exclu-
sion ofcarcinogens, this list differs from
the lists in Tables 5 through 7. The relative
amount ofeach compound is in propor-
tion to a single concentration as measured
by a flame ionization detector calibrated
with a single reference compound, toluene.
The concentrations of total VOCs mea-
sured in older dwellings (200-1700 pg/mi3)
were typically lower than in new homes
(500-19,000 pg/m3), with complaints
Table 7.Weighted median concentrations(pg/mi3) forairand breath samples obtained in thetotal exposure assessment methodolgy(TEAM)study.a
NewJersey North Carolina North Dakota
Compound Personal air Outdoorair Breath Personal air Outdoorair Breath Personal air Outdoorair Breath
Trichloroethane 17.0 4.6 6.6 32.0 60.0 - 25.0 >0.1 9.3
Benzene 16.0 7.2 12.0 9.8 0.4 15.0 - - 56.0
m,p-Xylene 16.0 9.0 6.4 6.9 1.5 3.8 6.2 >0.1 4.5
Tetrachloroethylene 7.4 3.1 6.8 3.3 0.7 3.9 5.0 0.7 8.0
Ethylbenzene 7.1 3.0 2.9 2.5 0.3 1.5 2.1 >0.1 1.4
o-Xylene 5.4 3.0 2.2 3.6 0.6 1.2 2.7 >0.1 2.7
p-Dichlorobenzene 3.6 1.0 1.3 2.6 0.4 1.2 1.7 >0.1 0.8
Chloroform 3.2 0.6 1.8 1.7 0.1 0.7 0.4 >0.1 2.9
Trichloroethylene 2.4 1.4 0.9 1.5 0.2 0.5 0.5 >0.1 0.9
Styrene 1.9 0.7 0.8 1.4 0.1 0.4 - - -
Carbon tetrachloride 1.5 0.9 0.7 - - -
aData adapted from Wallace(108).
Volume 103, Supplement 6, September 1995 259LEIKAUFETAL.
Table 8. Volatile organic compounds (VOC) and relative ratios approximated from sampling indoor environments
and used in controlled exposures.
Compound Ratio Compound Ratio
n-Butylacetate 1.0 a-Pinene 0.1
p-Xylenea 1.0 Methylethyl ketone (2-butanone)a 0.01
n-Butanol 0.1 Cyclohexane 0.01
n-Decane 0.1 Isopropanol 0.01
1-Decene 0.1 3-Methyl-3-butanone 0.01
1,2-Dichloroethanea 0.1 4-Methyl-2-pentanone 0.01
Ethoxyethylacetate 0.1 1-Octene 0.01
Ethylbenzenea 0.1 n-Pentanal 0.01
n-Hexanal 0.1 n-Propylbenzene 0.01
n-Hexanea 0.1 1,2,4-Trimethylbenzene 0.01
n-Nonane 0.1 n-Undecane 0.01
'Compounds included in Title ll-Hazardous Air Pollutants ofthe Clean AirAct 1990(see Table 1).
being more frequent when levels exceed
1700 pg/mr.
To investigate whether these com-
pounds influenced pulmonary functions
among persons with asthma, controlled 1.5
hr exposures were performed at concentra-
tion oftotal VOC of 2.5 and 25 mg/mi3
(113). At the end ofthe 25 mg/m3 expo-
sure, subjects developed bronchoconstric-
tion, with the FEV1 decreasing about 10%
from pre-exposure control. Individual
responses varied, with bronchoconstriction
more pronounced in individuals with the
greatest baseline airway hyperreactivity.
The effect of2.5 mg/m3 was not distin-
guishable from control. Subjective mea-
sures ofdiscomfort (odor, and eye, nose,
or throat irritation) first increased and
then diminished during exposure suggest-
ing acclimatization, and these responses
were similar in magnitude to those noted
in previous studies with healthy subjects
(111). Using a similar VOC mixture,
Koren and Delvin (114) also noted an
increase in nasal inflammatory cells in
lavage fluid immediately and 18 hr after a
4-hr exposure to 25 mg/n3. From these
studies, Molhave has offered tentative
guidelines for exposure to these com-
pounds in nonindustrial settings. At total
VOC levels of<200 pg/mi3, no discomfort
from odor, eye, nose, or throat irritation,
or headache is likely, whereas above 3000
pg/Mi3, complaints have occurred in most
investigated buildings; above 5000 pg/mr3
objective measures of upper respiratory
tract irritation increase markedly.
Epidemiologic information on the res-
piratory effects of environmental VOC
exposure is limited. One recent study, con-
ducted in Kanawha Valley, West Virginia,
found an association between exposure and
respiratory symptoms among schoolchild-
ren (third and fifth graders) (115).
Kanawha Valley was selected because it
contains several chemical manufacturing
plants within a valley topography that can
confine atmospheric mixing. Exposures
were categorized by school location (in or
out of the valley and near or far from an
industrial site) and by the sum ofthe con-
centrations of 5 petroleum-related chemi-
cals or 10 manufacturing process-related
chemicals. The concentrations of these
chemicals were measured at the elementary
schools and are presented in Table 9.
When exposure was characterized by either
proximity to sources or by concentrations,
a positive association with the incidence of
chronic lower respiratory symptoms was
noted. Moreover, children enrolled in
schools within the valley had higher rates
ofdoctor-diagnosed asthma. Importantly,
other potentially confounding variables
including parental smoking and familial
socioeconomic status had weak associations
with health outcomes and proximity to
sites. Nevertheless, these analyses adjusted
for these variables and the association of
chronic airway responses important to
asthma and exposure was still evident.
Although the Kanawha Valley is some-
what unusual in that it has several chemical
manufacturing sources, the levels of air
pollutants in this area are not extremely
different from those in other sites in the
United States. Table 10 presents the mean
and maximum concentration of 10 VOCs
(5 petroleum-related and 5 process-related
compounds) as measured in the Kanawha
Valley and four other locations. At each
location, the mean values are typically 0.1
to 0.5 ofthe maximal values. This suggests
that the concentrations of each substance
vary greatly within a location. The
between-location variability is also large.
For example, mean benzene concentrations
in Kanawha, Houston, and San Jose have
Table 9. Atmospheric concentrations (pg/M3) of 15
volatile organic compounds measured at 74 elementary
schools in Kanawha Valley, WestVirginia.a
Mean
(SD) Median Maximum
Petroleum-related
compounds
Toluene 9.7 (17.2) 4.8 117.4
m,p-Xylene 4.1 (3.8) 3.1 25.1
Benzene 3.2 (1.2) 3.0 6.9
o-Xylene 1.5) 1.1) 1.1 7.5
Decane 0.8 0.4) 0.7 1.9
Total 19.2 (22.3) 13.1 154.4
Process-related
compounds
1,1,1-Trichloroethane 1.0 0.2) 1.0 2.0
Carbon tetrachloride 0.6 0.2) 0.6 1.5
1-Butanol 0.6 0.4) 0.6 2.6
Chloroform 0.9 1.1) 0.6 7.9
Perchloroethylene 0.6 0.4) 0.5 2.2
Methyl isobutyl ketone 0.4 0.2) 0.4 0.9
1,2-Dichloroethane 0.3(0.1) G.3 0.6
Styrene 0.1 (>0.1) 0.1 0.2
Mesityl oxide 0.1 (0.1) >0.1 0.5
2-Ethoxyethyl acetate >0.1 (0.1) >0.1 0.6
Total 4.6 (1.7) 4.2 13.0
"Data from Ware (115).
3
been 3.2, 19.6, and 39.6 pg/mr, respec-
tively. Similarly, mean toluene concentra-
tions have been measured to be 9.7, 27.3,
and 79.5 pg/mi3, respectively, in these three
locations. It is important to consider that
each measurement can be influenced by
differences in sampling and analytical pro-
cedures and sampling times. These para-
meters varied between these studies,
making direct comparisons more qualita-
tive than strictly quantitative. Nonetheless,
because the values in Kanawha Valley do
not exceed the values in other locations, it
is possible that exposures like those ofthe
Kanawha Valley can occur elsewhere
throughout the United States.
In addition, several differences exist
between the findings from VOC exposure
in the controlled human experiments and
those in the epidemiologic KanawhaValley
Health Study. First, and most obvious, is
the difference in the concentrations at
which responses were noted. In the con-
trolled exposure study, no acute responses
3 were noted at 2500 pg/m , whereas 25,000
pg/mi3 decreased lung function. The total
VOC concentration in the KanawhaValley
was about 25 pg/mi3 (petroleum-related
mean VOC subtotal = 19.2 and process-
related mean VOC subtotal = 4.6 pg/mi3)
(Table 9). However, the populations (adult
vs children), the nature of the response
(acute bronchoconstriction vs chronic
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Table 10. Ambient concentrations (pg/mr3) ofvolatile organic comounds at selected sites in the United States.'
Mean concentrations
Kanawha Valley, WV San Jose, CA Downey, CA Denver, CO Houston, TX
Petroleum-related compounds
Toluene 9.7 (17.2) 80.0 64 13.0 27.0
m,p-Xylene 4.1 (3.8) 57.0 44 8.2 15.0
Benzene 3.2 (1.2) 40.0 28 7.1 20.0
o-Xylene 1.5 1.1) 25.0 18 2.7 5.9
Decane 0.8(0.4) - - - -
Process-related compounds
1,1,1-Trichloroethane 1.0 0.2) 6.7 6.3 3.5 2.0
Carbon tetrachloride 0.6 0.2) 0.9 1.2 1.6 1.8
Chloroform 0.9) 1.1) 0.5 0.7 0.6 1.2
Perchloroethylene 0.6(0.4) 13.0 25.0 2.9 1.1
1,2-Dichloroethane 0.3 0.1) - 0.4 >0.1 1.8
Maximum concentrations
Petroleum-related compounds
Toluene 117.0 173.0 241.0 97.0 294.0
m,p-Xylene 25.0 110.0 163.0 64.0 78.0
Benzene 6.9 75.0 92.0 43.0 129.0
o-Xylene 7.5 48.0 69.0 18.0 31.0
Decane 1.9 - - - -
Process-related compounds
1,1,1-Trichloroethane 14.0 17.0 15.0 10.0 6.7
Carbon tetrachloride 22.0 1.6 2.4 2.3 7.2
Chloroform 95.0 1.0 1.9 1.3 7.8
Perchloroethylene 3.7 45.0 25.0 17.0 11.0
1,2-Dichloroethane 17.0 - 2.5 0.5 9.8
"Mean and petroleum-related maximum values for Kanawha Valley were measured at 74 elementary schools in
November and December 1988. Adapted from Ware (115). Process-related maximum values for Kanawha Valley
were measured between April 1987 and March 1988. Adapted from Cohen (70). Values for other locations were
measured as follows: San Jose, April 1985; Downey, February 1984; Denver, April 1984; Houston, March 1984.
Adapted from Singh (116). SD is shown in parentheses.
symptoms and diagnosed asthma), and the
length ofexposure (90 min vs continuous)
are all different. In addition, the composi-
tion ofthe mixture (by a necessity that the
controlled exposure excluded carcinogens)
and the relative ratios varied in the total
mixture. It also should be noted that the
VOC compounds used in the controlled
exposure studies (e.g., alkanes, xylene,
benzene, or toluene) are not particularly
irritating to the respiratory mucosa. None-
theless, the clinical study supports the bio-
logical feasibility ofthe associations noted
in the epidemiological study.
Health Effects Assessment
CriteriaPollutants andMortality
Air pollution has been linked to adverse
health effects. Increased mortality from car-
diopulmonary disease and cancer has been
noted in areas with elevated air pollution
concentrations. Similarly, increased mor-
bidity has been associated with environ-
mental exposure (117,118). The latter
includes increases in respiratory symptoms
(e.g., shortness ofbreath, wheezing, cough-
ing, chest tightness), decreased pulmonary
function (e.g., depressed FEVI or PEF,
increased use ofbronchodilators, absence
from school or work, and increased hospital
admissions). As noted above, most previous
analyses ofthese associations have focussed
on criteria pollutants because much less has
been reported for other pollutants. Because
air pollution is a complex mixture, several
investigators have postulated that any sin-
gle exposure variable cannot solely be
responsible for observed adverse effects
(50,69, 119-121). Thus, measurements of
criteria pollutants also may serve as expo-
sure surrogates for a complex mixture of
criteria pollutants and UATs.
In the past, epidemiologic studies in
several cities throughout the United States
have examined the relationship between
mortality and the current criteria air pollu-
tants. Observations from these studies have
relevance to this assessment ofthe role of
UAT in asthma. As mentioned above, one
constant finding is the presence of covari-
ables that might explain the observed asso-
ciations. Weather, cigarette smoking,
migration, and ethnic/socioeconomic vari-
ables impact mortality; however, these vari-
ables act independently of specific
pollutants in these analyses. Numerous
studies have consistently observed associa-
tions between air pollution and mortality
in different populations, in different areas,
and at different times of the year
(37,42,50,60,122,123).
A second constant finding is the
influence of local sources on mortality.
Although this question has not been evalu-
ated rigorously and long-range transport is
recognized to influence ambient concentra-
tion, local sources can have strong influences
on the association of air pollutants with
mortality. A good example is the Harvard
Six Cities study in which local, stationary
sources in Steubenville, Ohio, and St.
Louis, Missouri, dominate air pollution
concentrations (50,124). Importantly,
these cities have higher mortality than
Watertown, Massachusetts, and Kingston/
Harriman, Tennessee. The latter cities have
moderate air pollution levels that are
attributable largely to long-range transport
processes ofpollutants into these airsheds
from other regions upwind ofthese com-
munities rather than from local sources.
The third constant finding is the order
ofthe relative strengths ofthe associations
between mortality and specific criteria pol-
lutants. Although controversial, these pol-
lutants can be ranked from strongest to
weakest as follows: PM2.5 > PM10 > SOX>
H+ 2 03 > NOX (30,37,41,50,115,121,
125-128). In most recent studies, particu-
late matter, a complex mixture containing
several UATs, is the dominant pollutant
(50,68,120,129). The strength ofthis rela-
tionship is remarkably consistent across
studies (128,130). In addition, association
with mortality has been reported for expo-
sures at concentrations well below the cur-
rent PM10 standard (150 pg/mi3). A recent
estimate ofthe total population exposed to
ambient PM10 levels in counties and cities
not in attainment with this standard is over
41 million, ofwhich approximately 1 mil-
lion adults and 625,000 children have
asthma (131). Because of the extent of
human exposure and the strength ofPM10
(a complex mixture) as an associated risk
factor, it is important to consider the
chemical composition ofthis pollutant.
Detailed chemical analyses of PM10
vary significantly from location to location
and data are limited (65,69,132,133).
Although apportionment ofPM10 may be
site specific, typically particles in the 2.5-
to 10-pm size range consist ofre-entrained
road dust [soil particles, engine oil includ-
ing metals, tire particles, sulfate (6% of
<10 pm), and nitrate (7% of <10 pm)],
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and construction and wind-blown dust
(mostly soil particles). Fine particles less
than 2.5 pm are derived primarily from
combustion, condensation, and coagula-
tion ofgases and ultrafine particles; thus,
particles in this smaller size range are
derived predominantly from anthropogenic
sources. Preliminary and tentative analyses
ofthe effect ofincluding particle source on
mortality estimates suggest that the least
significant indicator is soil, whereas auto
and oil sources are intermediate and metal
industry and coal combustion sources are
more significant contributors to mortality
(28,60).
EnvironmentalTobacco Smoke,
UATs, andAsthma
Environmental tobacco smoke (ETS) has
recently been associated with an increase of
asthma in children (134-136). Maternal
smoking is associated with an increase in
severity and frequency (additional
episodes) ofasthma in children with the
disease. Importantly, this exacerbation of
asthma and symptoms related to asthma
mayoccur atlowdoses.
ETS is a complex mixture ofover 4000
chemicals from exhaled mainstream and
sidestream smoke. ETS contains several
human respiratory carcinogens (including
benzo[a]pyrene, benz[a]anthracene, other
polycyclic aromatic hydrocarbons, 4-amino-
biphenyl, and nitrosadi-methylamine) and
irritants (including formaldehyde, acrolein,
other aldehydes, cadmium, and other met-
als) (136,137) (Table 11). Twenty-nine of
the 49 major components in ETS are UATs
(compare Table 1 with Table 11). Each is a
complex mixture ofchemicals in both gas
andparticle phase. Because ofthese similar-
ities, it is relevant to compare and contrast
ETS and UATs in asthma.
ETS exposure has been assessed by
measurement of a number of its con-
stituents in air. Nicotine, respirable sus-
pended particulate (RSP = PM < 2.5 prm),
benz[a]pyrene, benzene, formaldehyde,
toluene, carbon monoxide, 4-amino-
biphenyl, and other chemicals have been
used to assess ETS exposure. Of these,
nicotine and RSP have the widest applica-
tion, and these two variables correlate rea-
sonably XRSP = 17.9 ± 10.8 nicotine; each
in pg/mr) (138). Either measure has been
used as ETS exposure surrogates, andwhen
measured together can accurately represent
the frequency, duration, and magnitude of
ETS exposure (136).
Because nicotine is not suspected of
inducing asthma and is not a UAT, and
because RSP contains many compounds
that affect asthma and are UATs, a prelimi-
nary evaluation ofthe magnitude ofRSP
exposure associated with increased asthma
is worthwhile. The amount of RSP
produced in the breathing zone ofa child
will vary with the number of smokers,
proximity to the smokers, ventilation, and
other variables. Nonetheless, average room
RSP concentrations (obtained from 2 4 hr
samples) are typically elevated by 2 to 5
pg/m3 per cigarette smoked in an average
size room (138). Background indoor RSP
levels vary depending on other indoor
aerosol sources and the amount ofpenetra-
tion of the ambient aerosol [this can be
substantial (50-80%) for particles in this
size range], and typically are 15 pg/mr3
[Table 12; (65)]. Smoking typically can
bring RSP levels up to 45 pg/m3 (with a
range of18-95 pg/mr3) (138-140).
Increases in the incidence and preva-
lence ofasthma among children have been
noted when mothers smoke 10 or more
cigarettes per day (141,142). Applying the
findings ofLeaderer et al. (138), we calcu-
late that 10 cigarettes would generate an
atmosphere containing 20 to 50 pg/mr3
RSP above background and result in total
exposure to approximately 35 to 65 pg/mr3
RSP. Exposures in this range have been
estimated to induce 8000 to 26,000 new
cases of asthma annually (based on esti-
mates ofmaternal smoking). It is feasible
that UAT exposures, when mixed with the
respirable particulate load in this range,
also could adversely impact persons with
asthma. This level ofparticulate exposure is
Table 11. Majorchemicals in environmental tobacco smoke.
Vapor phase
>1000 pg/cigarette in mainstream smoke
Carbon monoxide
1000 > x> 100 pg/cigarette in mainstream smoke
Toluenea
Acetaldehydea
Methyl chloride
Nitrogen oxides
Acetic acid
Hydrogen cyanide
Formic acid
100 >x> 1.0 pg/cigarette in mainstream smoke
Formaldehyde
Benzenea
Acroleina
Propionaldehydea
1,3-Butadienea
Styrenea
Carbonyl sulfide
3-Vinylpyridine
3-Methylpyridine
Methylamine
Dimethylamine
Ammonia
>1.0 pg/cigarette in mainstream smoke
Hydrazinea
N-Nitrosodimethylaminea
N-Nitrosodiethylamine
N-Nitrosopyrrolidine
Particulate phase
Nicotine
Phenola
Catechola
Hydroquinonea
Quinolinea
Cresols'
Anatabine
y-Butyrolacetone
4-Aminobiphenyla
2-Toluidinea
N-Nitrosodiethanolamine'
Cadmiuma
Nickel'
Chromiuma
Polycyclic aromatichydrocarbons' Benz[alanthracene
Benz[ajpyrenea
Anilinea
Polonium-210a
Dioxinsa
Zinc
2-Naphthylamine
4-(N-Methyl-N-nitrosamino)-1 -(3-pyridyl)-1-butanone
N-Nitrosonornicotine
1-Methyl-9H-pyrido[3,4-b]-indole
'Compounds included in Title ll-Hazardous Air Pollutants of the Clean Air Act 1990. Concentrations are from
IARC(137) and U.S. EPA(136).
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Table 12. Average ambient aerosol concentrations (pg/mr3) in sixcities in the United States.a
City Total suspended particulate PM10 PM2.5 PM2d.^PM1o
Portage, WI 34 18 11 0.61
Topeka, KS 57 26 13 0.50
Watertown, MA 49 24 15 0.63
Harrison, TN 49 33 21 0.64
St Louis, MO 73 31 19 0.61
Steubenville, OH 90 47 30 0.64
'Values for total suspended particulate are from 1977 to 1985; PM10 and PM25 from 1979tol'985. From Dockery
(50).
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Figure 3. Increase in the percentage of children with
the respiratory symptom of wheeze associated with
maternal smoking. From Newspiel (143). Table (insert)
includes estimated values of respirable suspended
particulate calculated from data presented by Leaderer
(138).
well below the current PM10 ambient air
standard of 150 pg/m3.
Other studies have examining the rela-
tionship between ETS generated by moth-
ers and respiratory symptoms (wheeze,
etc.) associated with asthma in children.
The data in Figure 3 suggest an association
with an increase in symptoms with an
increase in maternal smoking (143). Again,
an adverse response was noted at relatively
low levels ofexposure of 1 to 4 and 5 to 14
cigarettes per day smoked by the mother.
Applying the estimates of RSP produced
by these exposures yields estimated concen-
trations of added particulate of 2 to 20
pg/mi3 and 17 to 35 pg/mi3 above back-
ground. Similarity, Lebowitz and
Quakenboss (144) reported that exposures
to 2 20 cigarettes/day (or 40-100 pg/mi3)
produces 3.6 times more bronchial hyper-
reactivity, a characteristic sign ofasthma.
Several factors are uncertain in these
comparisons, however. First, because
maternal smoking has a greater effect than
paternal smoking, it also may influence the
development ofasthma in utero by limiting
lung development (145-147). In addition,
average concentrations ofroom air samples
may underpredict the levels in a child's
breathing zone because small children are
often held by their mothers. This proxim-
ity could result in complex exposure
patterns of intermittent high-level expo-
sures ofshort duration. Conversely, older
children spend less time at home or in a
room with a parent who smokes. Exposure
patterns to UATs also may be intermittent,
with wide variances in concentration.
Thus, it is important to obtain time-activ-
ity information to predict personal expo-
sures by combining microenvironmental
concentration information with duration
ofexposure obtained from time-activity
analyses.
Second, the physical and chemical
properties ofETS differ from those ofthe
ambient mixture ofgaseous and particulate
UATs. Although several main irritants are
contained in both, the levels of most are
greater in ETS than in urban air. The par-
ticle size also may differ in that ETS is <
1.0 pm [sidestream smoke is typically
0.001-1.0 pm and mainstream smoke is
0.1-1.0 pm in diameter (148)], whereas
the cutoffdiameter ofPMIO in the ambient
aerosol containing UATs is 10 pm. Besides
mass concentration (i.e., pg/mi3), certain
aspects ofparticulate toxicity depend on
the number of particles (149-151).
Because mass depends on particle volume,
small increases in diameter in this range
can have large influences on the reduction
number of particles. Thus, particles
between 1.0 to 10 pm add greatly to the
mass estimates of UATs in air.
Nonetheless, ambient fine (<2.5 pmr par-
ticulate between 11 and 30 pg/m and
inhalable (< 10 pm) particulate between 18
and 47 pg/mi3 has been associated with
increase in cardiovascular and respiratory
disease (50).
An Evaluation of Human
Exposure and Its Relationship
to Asthma
Identification CriteriaforUATs
Likely to Impact Asthma
Reversible, acute airflow obstruction (indi-
cated by diminished expiratory flow that
can be reversed by adrenergic therapy) pro-
duced by direct exposure in a clinical
setting has become a useful operational
definition for the evaluation ofchemically
induced asthma (5,101). Through direct
bronchoprovocation with a series of com-
pounds, certain chemicals have been
identified to produce marked responses.
Common asthmagens identifiable by this
method include metals (chromium triox-
ide, chromates, nickel sulfate, and platinum
compounds). Such an approach is particu-
larly useful in diagnosis of occupational
asthma and is aided by knowledge of the
chemicals present in the workplace and the
reversal of symptoms upon their removal
from theworkplace. Although much can be
learned by this diagnostic strategy, it may
be impractical to apply this approach to
future evaluations of the toxicity of over
189 compounds.
Further, certain known occupational
asthmagens act by an immunologic mecha-
nism in some persons, but not in others.
These compounds include polyisocyanates,
acid anhydrides, and aldehydes. In these
cases, the threshold concentration needed
to produce bronchospasm is likely to below
that necessary to induce nonimmunospecific
irritation. Other substances (acting like
sulfur dioxide and perhaps ozone) do not
produce antigenic responses but can pro-
voke bronchoconstriction in persons with
asthma at concentrations that are lower
than those that are bronchoconstrictive in
healthy subjects. These chemicals may act
as an irritant and have an ability to induce
airway epithelial injury and inflammation,
effects that can be barely perceptible at
doses in the range occurring in the envi-
ronment. Released from stationary sources,
such UATs can mix with other toxic chem-
icals in the urban air and add to the irritant
load presented to persons with asthma in
the general population.
Many UATs have insufficient scientific
data to evaluate their immunologic poten-
tial, however. Because of this situation,
because it is difficult to limit the definition
of asthma to antigenic responses, and
because of difficulties in ascertaining
whether each chemical by itself causes or
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Table 13. Estimates ofenvironmental concentrations ofairtoxics suspected of being human asthmagens.
Past exposure levels, pg/mi3
Compound Occupational Nonoccupational Fugitive emissions
Aldehydes
Acrolein 130-7200 32 320-640
Formaldehyde >370 0.05-70.1
Propionaldehyde - -
Acetaldehyde 1200-3400 0.4-124
Polyisocyanates/Isocyanates
Toluene diisocyanate 14-1050 0-150 100-17,700
Hexamethyl diisocyanate 1000-3780
Methylene diphenyl diisocyanate 102-204
Methyl isocyanate -
Acidic anhydrides
Maleic anhydride -
Phthalic anhydride 3000-13,000
Metals
Cadmium 15-5000 3-50
Chromium >1300 0.009-0.300 >1000
Chromate (VI) 38-1000
Cobalt 70-500 0.01
Nickel 500-900 0.005-0.035 0.124-0.328
Others
Hydrazine 350-1100 4000
p-Phenylenediamine -
exacerbates asthma through clinical experi- tance among the scientific community as
mentation (152), the broader chemical to their effects in occupational settings.
properties ofUATs need to be considered. Other UATs share a portion of these
Properties that are important to this ques- properties, but it is unclear whether they
tion include respirability, irritancy, and can induce persistent asthma. Adding to
skin antigenicity. the difficulty of this situation are the
Several compounds identified as UATs uncertainties created by the gaps in the lit-
share these properties and can clearly be erature regarding the human toxicity of
classified as suspected human asthmagens. each compound. Nonetheless, to develop
These compounds are listed in Table 13. logical strategies to assess possible links
These compounds have had documented between environmental exposure to these
reports in the medical literature associating compounds and asthma, the limited
human exposure with asthma (either as human experience must be considered.
inducers or exacerbaters). This includes This second group ofcompounds (Table
polyisocyanates, aldehydes, anhydrides, 14) includes skin allergens (compounds
and metals-compounds with wide accep- producing allergic contract dermatitis)
Table 14. Concentrations ofairtoxics suspected ofbeing respiratory irritants (exacerbators) in asthma.
Past exposure levels, pg/mi3
Compound Occupational Nonoccupational Fugitive emissions
bis-Chlormethyl ether 0-14,100
Dimethyl carbamyl chloride 300-7000
Dimethyl sulfate 42-5290
Phosgene 520-4000
Phosphine 60-370
Chlorine 1000-2900 30
Coke oven emission 0.06-0.56 0.03-0.14
P-Propiolactone
Chlorine 1000-2900 30 >3000
Hydrogen fluoride 890 0.16-1.9
Dioctyl phthalate 8000-53,000 0.026-0132
Dibutyl phthalate - 0.033-0.006
Dimethyl phthalate -
Hydrochloric acid 500-15,000
Hydrogen sulfate >140,000
with chemical properties that suggest
inhalation as a route of exposure
(153,154). This includes hydrazine, p-
phenylenediamine, nickel, and chromium
compounds. In addition, other compounds
known to react covalently with proteins or
DNA include polycylic aromatics/aryl
epoxides, bis-chloromethyl ether, dimethyl
carbonyl chloride, dimethyl sulfate, and 0-
propiolactone. These compounds can act
directly by forming specific immunoglobu-
lin complexes or indirectly by forming
haptens or other antigenic determinants to
produce adverse responses in the airways
(155-158). Carcinogenic compounds can
cause irritation and inflammation at sites of
exposure and are often antigenic
(159-164).
Last, potent respiratory irritants with
wide-scale usage are included in this list.
Substances such as cadmium compounds,
chlorine, hydrochloric acid, hydrogen
fluoride, phosgene, phosphine, and hydro-
gen sulfide are known irritants to the respi-
ratory tract, and in some cases have been
responsible for community air pollution
episodes involving accidental emissions
(e.g., rail carderailments).
Noticeably not included on these lists
are UATs that are also VOC compounds
listed in Tables 5 through 8. As noted
above, these compounds have been associ-
ated with increased asthma symptoms in
controlled human studies (111,113,114)
and epidemiologic studies (165). However,
because these studies measured exposures to
mixtures and because many ofthe com-
pounds listed have not been associated with
asthma or other respiratory effects, these
compounds have not been included in this
tentative list. Investigations ofhuman expo-
sures to these compounds separately and as
mixtures are likely to yield additional
insights into their possible role in inducing
asthma and therefore will beworthwhile.
Our literature review ofother UATs
listed in Table 1 suggests that they may be
of lesser concern. It is appreciated that
these compounds also may contribute (par-
ticularly as mixtures) to other serious
health outcomes, and therefore inclusion of
compounds with high enough priorities for
more immediate consideration should be
based on these effects. (Examples include
benzene and 1,3-butadiene.)
EstimatesoftheMagnitude
ofExposure toAs
The extent of human exposure must be
considered in the evaluation ofthe role of
UAT in asthma. Because air sampling is
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not routinely performed on each ofthese
compounds, the lack ofscientific informa-
tion requires caution. One approach is to
consider the extent ofoccupational expo-
sure as an indication ofpossible sources of
emissions. Recently, Seta and coworkers
(166) estimated that over 6 million workers
are potentially exposed to chemical or
metal asthmagens at industrial settings
throughout the United States. (Potential
exposure to polyisocyanates alone exceeded
110,000 workers.) At a minimum, this
suggests that several point sources exist that
can potentially contribute to community
air pollution. Historic levels reported in
occupational settings are presented in
Table 15. Estimated release of asthmagens into the
air, 1990.a
Compound Facilities Pounds, x 1000
Styrene 1,398 31,817
Formaldehyde 871 12,309
Acetaldehyde 80 7,179
Propionaldehyde 18 989
Nickel and compounds 2,111 923
Phthalic anhydrides 188 689
Methylene diphenyl 589 665
diisocyanate
Maleic anhydride 226 493
Chromium and compounds 201 150
Toluene diisocyanate 172 113
Cadmium and compounds 254 104
Cobaltand compounds 201 37
Hydrazine 54 27
Acrolein 16 22
Methyl isocyanate 8 14
p-Phenylenediamine 12 1
Total 6,399b 55,532b
'Values are estimates from U. S. EPA (167). bAssumes
no overlap in usage (may be an overestimate if more
than one compound is used).
Table 16. Estimated release into the air of urban air
toxics suspected ofexacerbating asthmagens, 1990.a
Compound Facilities Pounds, x 1000
Respiratorycarcinogens
bis-Chlormethyl ether 3 5
Polycylic aromatics - -
P-Propiolactone
Dimethyl carbonyl chloride - -
Respiratory irritants
Chlorine 1747 105,072,589
Dibutyl phthalate 152 130,027
Dimethyl phthalate 62 333,555
Dimethyl sulfate 31 9,739
Dioctyl phthalate 353 1,344,752
Hydrochloric acid 3347 77,389,964
Hydrogen sulfide - -
Hydrogen fluoride 531 8,736,302
Phosgene 35 4,854
Phosphine - -
Values are estimates from U.S. EPA(167).
Tables 13 and 14. Information on the level
ofcurrent exposures is limited and requires
additional study.
Another approach to estimate the
extent ofexposure is to consider the emis-
sion inventories recently compiled by the
U.S. EPA. Table 15 lists UAT compounds
that are known or suspected asthmagens
and presents the number offacilities and
the total amounts estimated to be released
into the air. These values are for the
amounts released directly into the air and
do not include estimates of intermedia
transport or other pathways that might
result in inhalation exposures in the ambi-
ent air. Styrene (168-170), formaldehyde
(171), and acetaldehyde (172) are the
three chemicals with the greatest number
of reporting sources and with the greatest
amount ofrelease. In 1990, the total esti-
mated release into the air of these 16
asthmagens was over 55 million pounds.
Release inventories for other UATs that
might influence the respiratory health of
persons with asthma are listed in Table 16.
The highest levels ofrelease are reported
for chlorine and hydrochloricacid, two res-
piratory tract irritants. The estimated
release of respiratory carcinogens is low.
Estimates ofthe release ofpolycyclic aro-
matic hydrocarbons, however, are unlikely
to be accurate because this value does not
include amount produced by combustion.
In addition, emission inventories are, at
best, onlyqualitative and mayserve as indi-
cations ofthe magnitude ofpoint sources.
These estimates have not been validated by
air sampling near point sources. Further-
more, recent studies in California suggest
that models of air toxic exposures using
inventories often underestimate the actual
measured concentrations downwind from
stationary sources (MA Marty, personal
communication). Nonetheless, the large
number ofpossible point sources indicates
that extensive human exposure is possible.
In addition, predictions ofambient con-
centrations require applications ofair quality
dispersion models ofchemical-specific data.
It is unclear whether inventory data have
enough fidelity for such applications.
Another important gap in the literature is
whether cumulative effects result from
multiple acute exposures at high levels.
Release inventories only present estimates
ofannual averages and therefore lack detail
formodeling elevated acute exposures.
GurrntExosureGuidelines
Tables 17 and 18 present concentration
guidelines for occupational and nonoccu-
pational exposure. Included in these tables
are the current ACGIH-TLVs (threshold
limit values from the American Conference
ofGovernmental Industrial Hygienists) for
time-weighted averages for occupational
exposures for a normal 8-hr workday and a
40-hr workweek, to which nearly all
workers can be repeatedly exposed, day
after day, without adverse effects. Impor-
tantly, bronchoprovocation challenges
typically start at these concentrations, and
occupational asthma is often defined by a
decrease in lung function occurring at or
below these values. Consequently, these
values are unlikely to provide an adequate
margin ofsafetyfor the general population.
In addition, a comparison of the lowest
odor threshold presented in Tables 5 and 6
and the TLVs presented in Tables 17 and
18 indicates that odor thresholds are often
above recommended exposure limits, sug-
gesting that when odor is detected,
significant exposure can occur.
Also presented in Tables 17 and 18 are
guidelines for exposure in the ambient air.
Ambient air level goals (AALG) were
obtained from a monograph by Calabrese
and Kenyon (174). These guidelines are
based on calculation from no observed
effects level (NOEL) or lowest observed
effects level (LOEL) corrected for lifetime
exposure and divided by appropriate multi-
plicative uncertainty factors (as much as
1000 over the NOEL). When animal toxi-
city data are used, adjustments are made
for the equivalent human breathing rates
using species-specific equations and
absorption factors.
Also presented in Tables 17 and 18 are
the current reference exposure levels
(RELs) developed for California (175).
Exposure to each substance independently
at or below these values is not expected to
result in adverse (noncancer) health effects
following estimated 1-hr maximum con-
centrations (acute) or annual average
(chronic) for inhalation. To compare these
values with the cancer unit risk, the latter
must be multiplied byan exposure estimate
(concentration x number of persons
exposed). A major difference between these
two values is that cancer unit risks are
derived by linear extrapolation, assuming
no threshold. In contrast, RELs assume a
threshold (based on the NOEL presented
by IRIS and other sources). One way to
compare these values is to assume lifetime
exposure of one million people to a con-
centration (in pg/mi3) equal to the cancer
unit risk. For example, ifa community of
one million is exposed to 2.7 pg/mi3
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Table 17. Air exposure limits/guidelines and cancer unit risks forasthmagens.
California reference exposure levels Cancer
ACGIH-TLV,8 ALG,b Acute Chronic, unit risk
Compound pg/mi3 pg/mi3 pg/mi pg/m3i (pg/m3x 10F6
Acid anhydrides
Maleic anhydride 1,000 20.0 10.0 2.4
Phthalic anhydride 6,000 300.0 {7000} - -
Aldehydes
Acetaldehyde 45,000 - - 9.0 2.7
Acrolein 230 0.037 2.5 0.02 -
Formaldehyde 370 0.062 370.0 3.6 6.0
Metals
Cadmium and compounds 10 0.00011 - {3.5} 4,200.0
Chromium and compounds 50 0.00002 - 0.002 14,000.0
Cobalt and compounds 50 0.24 - - -
Nickel and compounds 100 0.00036 1.0 0.24 260.0
Polyisocyanates
Methylene diphenyl
Diisocyanate 51 0.6 - - -
Toluene diisocyanate 36 - - 0.095 11.0
Othercompounds
Hydrazine 100 0.0001 - 0.24 4,900.0
Methyl isocyanate 47 - - 0.36 -
p-Phenylenediamine 100 - - - -
Styrene 213 26.0 - {700} 0.57
Values are threshold limit values (TLV) for time-weighted averages for occupational exposures for a normal 8-hr
workday and a 40-hr workweek, to which nearly all workers may be repeatedly exposed, day after day, without
adverse effect. Data from American Conference of Governmental Industrial Hygienists (173). bAmbient air level
goal (AALG) as presented by Calabrese and Kenyon (174). CReference exposure levels as presented by California
Air Pollution Control Officers Association (175). Exposures to a single substance at or below this level is not
expected to result in adverse (noncancer) health effects following estimated annual average for inhalation
(chronic) or estimated 1-hr maximum concentrations (acute). Values in brackets {} are based on oral acceptable
exposure levels. dCancer unit risks are cancer potency values or preliminary potency values from California Air
Pollution Control Officers Association (175). Exposure estimates multiplied bythese values equal individual cancer
risk for exposure to a single compound.
Table 18. Airexposure limits/guidelines and cancer unit risks forcompounds suspected ofexacerbating asthma.
California reference exposure levelsC Cancer
ACGIH-TLV a ALGb Acute Chronic, unit risk,
Compound pg/mi pg/mi pg/mi pg/m3 (pg/m3x 106F
Respiratory carcinogens 7
bis-Chloromethyl ether 4.7(Al)e 2.0 x 10- - _ 13,000
Polycyclic aromatics (A2) - - - 1,700
P-Propiolactone 1,500.0 (A2) -
Dimethyl carbonyl chloride (A2) - - -
Respiratory irritants
Chlorine 1,500.0 17.0 23 7.1
Dibutyl phthalate 5,000.0 44.0 - -
Dimethyl phthalate 5,000.0 700.0
Dimethyl sulfate 520.0(A2) - - - -
Dioctyl phthalate - - - - -
Hydrochloric acid 7,500.0 150.0 3,000 7.0 -
Hydrogen sulfide 14,000.0 - 42 42.0 -
Hydrogen fluoride 2,600.0 - 580 5.9 -
Phosgene 400.0 - 12 - -
Phosphine 4,200.0 - - {10} -
Values are threshold limit values (TLV) for time-weighted averages for occupational exposures for a normal 8-hr
workday and a 40-hr workweek, to which nearly all workers may be repeatedly exposed, day after day, without
adverse effect. Data from American Conference of Governmental Industrial Hygienists (173). bAmbient air level
goal (AALG) as presented by Calabrese and Kenyon (174). CReference exposure levels as presented by California
Air Pollution Control Officers Association ( 175). Exposures to a single substance at or below this level is not
expected to result in adverse (noncancer) health effects following estimated annual average for inhalation
(chronic) or estimated 1-hr maximum concentrations (acute). Values in brackets {} are based on oral acceptable
exposure levels. dCancer unit risks are cancer potency values or preliminary potency values from California Air
Pollution Control Officers Association (175). Exposure estimates multiplied bythesevalues equal individual cancer
risk for exposure to a single compound. "Designations of Al and A2 are given by the ACGIH for confirmed and
suspected human carcinogens, respectively.
acetaldehyde, control actions are recom-
mended based on a cancer risk (rather than
based on the chronic REL that is 9.0
Pg/m ). Similarly, styrene exposures are lim-
ited more by the estimates for cancer risk
than bythe chronic REL. For the remainder
ofcompounds in Table 17 that have both a
cancer unit risk and chronic REL value
(formaldehyde, cadmium, chromium,
nickel, toluene diisocyanate, and hydrazine),
exposure is to be limited based more on the
chronic noncancer effects.
It is noteworthy that IRIS or other
documentation ofthesevalues does not con-
sider the possibility ofinduction or exacer-
bation ofasthma specifically as a basis for
chronic noncancer effects. NOEL for these
compounds are primarily selected by the
estimates ofrespiratory irritation. For exam-
ple, formaldehyde's ACGIH-TLV and IRIS
values are based on the data obtained on
irritation, and not on potential to induce
asthma or animal carcinogenesis data (173).
Because the diagnosis of occupational
asthma involves pulmonary responses that
are reported at or below the TLV, exacerba-
tion ofasthma can occur at doses ofthese
compounds below those that induce irrita-
tion. Therefore, the TLV and NOEL do
not always account for the exacerbation of
existing asthma. Inasmuch as sensitization is
ofmore relevance when considering safe-
guarding a heterogeneous general popula-
tion compared to an occupational
population, these exposure guidelines
should be considered tentative until further
information can be obtained on the rela-
tionship between levels that produce irrita-
tion and asthma in industrial settings, and
asthma in the nonoccupational settings.
Future Research Priorities
ExposureAssessment
Future scientific investigations are needed
to evaluate the possible links between
UATs and asthma. Currently, little infor-
mation exists on human exposure to these
compounds. In particular, emission release
inventories have yet to be validated by
environmental sampling. Another unset-
tled issue specific to these compounds is
the relative extent of indoor exposure.
Because these compounds are in ETS,
involuntary exposures are likely to be fre-
quent. Aldehydes have several other indoor
sources including wood fires and release
from building materials, personal care
products, and clothing (171). Initially,
field investigations could assess total expo-
sures to aldehyde and metal asthmagens
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using probability-based sampling. One
exposure aspect that is important in the
induction ofasthma is that the magnitude
of peak concentrations and ambient air
samples should include variant sample
times ifpossible. Last, this group ofcom-
pounds is ideal for future investigation of
fugacity models and it would be helpful to
know the amount ofintermedia transport
for these compounds, particularly the less
volatile organic compounds.
HealthEffcsAssessment
Because these compounds are highly toxic
and in some cases carcinogenic, further
human clinical testing is unlikely.
Consequently, in vitro toxicology testing
with human cell culture systems may be an
acceptable alternative. End points impor-
tant to airway inflammation, for example
cytokine and eicosanoid production,
should be examined to establish dose-
response information. These end points
can readily be investigated in laboratory
animals. Unfortunately, animal models of
asthma have limitations, with most previ-
ous investigations focusing on acute,
reversible airway hyperreactivity instead of
persistent chemically induced asthma.
Although small rodents (mice in particular)
have advantages for measurement ofmole-
cular end points (e.g., detection ofmRNA
for key cytokine by in situ hybridization),
these species are often less responsive than
humans and make tests oflung functions
difficult. Larger laboratory species (e.g.,
guinea pigs), in contrast, have disadvantages
in that molecular end points are harder to
measure (requiring gene cloning to generate
riboprobes for this species) but are useful
in evaluation of airway bronchocon-
striction and hyperreactivity. The effects of
chronic inhalation exposure to the UATs
and the induction ofpersistent hyperreac-
tivity is worthy offuture investigations. In
addition, information is needed on the
dose related to continuation ofa persistent
syndrome in animals that already have
hyperreactivity. Animal data on the effects
ofcomplex mixtures, including exposure to
two or more UATs, UATs with particulate
matter, or UATs with criteria pollutants
also could be investigated with animals.
Dose-response data would be helpful
to evaluate a current assumption made in
risk assessment that the effect ofeach sub-
stance is additive for a given organ system.
This assumption is contradicted by studies
with respiratory irritants that suggest
synergy can occur, e.g., acid sulfates diox-
ide and metal aerosols (176). Currently,
ambient air quality standards are based
largely on data obtained when each criteria
pollutant is tested independently. Indeed,
concerns about exceedances are based on
the expected adverse effects ofthe pollutant
in highest concentration (often ozone)
without concern about coexposure to other
irritant pollution present in the typical oxi-
dant urban plume. For example, urban
concentrations of aldehydes and other
volatile organic compounds follow diurnal
patterns and have peaks above 50 pg/mi3
(171). These exposures can occur with
subsequent high ozone exposures (>250
pg/Mi3), and recent epidemiological studies
tentatively suggest that pollution interac-
tions may potentate respiratory responses
(177). (Note that formaldehyde, acetalde-
hyde, and acrolein exposures often occur
together in concentrations that exceed the
RELvalues presented inTable 17.)
The number of persons living near
emitting point sources is unknown but
could be derived from census data and
information on the location of point
sources throughout the United States.
Furthermore, the percentage ofpersons in
these populations that have asthma can be
estimated based on NHANES survey. It
would be useful to estimate the extent of
exposure to these identifiable asthmagens.
Such data could be useful in assessments of
health care costs (178).
Last, the current epidemiological infor-
mation on the possible associations
between UATs and asthma is inadequate.
Recent studies with criteria pollutants sug-
gest that animal and clinical exposure data
can underestimate respiratory health
effects. One epidemiological study of
formaldehyde suggests that children
exposed in homes with concentrations of
>150 pg/mi3 had a higher frequency of
asthma and bronchitis than children with
residential exposure <50 pig/mi3 (179).
Decrements in PEF were also correlated
with formaldehyde exposure. Clinical stud-
ies with formaldehyde, in contrast, require
much higher concentrations to produce
transient increases in airway resistance
(171). This suggests that persistent respira-
tory effects can result from indoor
formaldehyde exposures and that environ-
mental exposures produce effects not
observed in clinical studies with short-term
exposures. Confirmation through addi-
tional investigation ofthe effects ofenvi-
ronmental aldehyde and other UAT
exposure on persistent pulmonary function
is thus warranted.
Conclusions
In summary, asthma is a serious illness
with a high prevalence among the general
population. Over the last 15 years, the
incidence and severity ofasthma have con-
tinued to increase. In the past, exposure to
air pollution has been associated with an
increase in respiratory symptoms and hos-
pital admissions for asthma. The role of
UATs in this condition (with and relative
to other known hazardous compounds in
air pollution) has yet to be explored thor-
oughly. Nonetheless there is good reason
to think that certain compounds may be
etiological factors in asthma.
Several UATs are known comounds or
are related to compounds that are occupa-
tional asthmagens. Environmental agents
associated with asthma include ambient
particulate matter and environmental
tobacco smoke; both are complex mixtures
containing many compounds that are
UATs. Last, several UATs that have not
been reported to produce asthma directly
may be particularly hazardous to persons
with asthma because they can exacerbate
asthma through repetitive irritation ofair-
way epithelium. Other UAT compounds
have antigenic potential and can be
inhaled. The latter includes respiratory car-
cinogens that can form antigenic determi-
nants through alkylation reactions with
cellular macromolecules. Further research
is needed to clarify the issues surrounding
the extent of human exposure and the
potential role ofUATs in asthma.
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